Beyond the Status Quo: Exploring the Future Impact of HBV Innovations

Nov 10 2025

Convention Center: Room 152, Level 1

12:30 PM - 2:00 PM

Description

This engaging symposium will provide insights into recent innovations in the management of chronic hepatitis B. Expert faculty will discuss emerging biomarkers, investigational therapies aimed at chronic viral suppression and functional cure, and how these advances may help address existing gaps in care and improve long-term patient outcomes.

Supported by: Aligos Therapeutics
Organized by: Clinical Care Options, LLC

For more information and to register, visit:

Journey Maps

Hepatitis

Objectives

Evaluate the limitations of current antiviral therapy for HBV.
Outline the role of emerging biomarkers in evaluating disease status and treatment response for patients with HBV.
Examine the role of emerging agents for chronic HBV suppression and their potential to improve patient outcomes.